Literature DB >> 15205335

Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death.

Anne Jarry1, Laetitia Charrier, Chantal Bou-Hanna, Marie-Claire Devilder, Véronique Crussaire, Marc G Denis, Geneviève Vallette, Christian L Laboisse.   

Abstract

Mounting evidence suggests that the position in the cell cycle of cells exposed to an oxidative stress could determine their survival or apoptotic cell death. This study aimed at determining whether nitric oxide (NO)-induced cell death in colon cancer cells might depend on their position in the cell cycle, based on a clone of the cancer cell line HT29 exposed to an NO donor, in combination with the manipulation of the cell entry into the cell cycle. We show that PAPA NONOate (pNO), from 10(-4) m to 10(-3) m, exerted early and reversible cytostatic effects through ribonucleotide reductase inhibition, followed by late resumption of cell growth at 5 x 10(-4) m pNO. In contrast, 10(-3) m pNO led to late programmed cell death that was accounted for by the progression of cells into the cell cycle as shown by (a) the accumulation of apoptotic cells in the G(2)-M phase at 10(-3) m pNO treatment; and (b) the prevention of cell death by inhibiting the entry of cells into the cell cycle. The entry of pNO-treated cells into the G(2)-M phase was associated with actin depolymerization and its S-glutathionylation in the same way as in control cells. However, the pNO treatment interfered with the build-up of a high reducing power, associated in control cells with a dramatic increase in reduced glutathione biosynthesis in the G(2)-M phase. This oxidative stress prevented the exit from the G(2)-M phase, which requires a high reducing power for actin deglutathionylation and its repolymerization. Finally, our demonstration that programmed cell death occurred through a caspase-independent pathway is in line with the context of a nitrosative/oxidative stress. In conclusion, this work, which deciphers the connection between the position of colonic cancer cells in the cell cycle and their sensitivity to NO-induced stress and their programmed cell death, could help optimize anticancer protocols based on NO-donating compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205335     DOI: 10.1158/0008-5472.CAN-04-0254

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).

Authors:  F Yang; P Shi; X Xi; S Yi; H Li; Q Sun; M Sun
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Human colonic myocytes are involved in postischemic inflammation through ADAM17-dependent TNFalpha production.

Authors:  Anne Jarry; Kalyane Bach-Ngohou; Damien Masson; Thomas Dejoie; Paul-Antoine Lehur; Jean-François Mosnier; Marc G Denis; Christian L Laboisse
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis.

Authors:  Roberto Gabriel Pozner; Soledad Negrotto; Lina Paola D'Atri; Mónica Lidia Kotler; María Angela Lazzari; Ricardo Martin Gomez; Mirta Schattner
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle.

Authors:  Deepthi Menon; Philip G Board
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

Review 5.  Reversible and irreversible protein glutathionylation: biological and clinical aspects.

Authors:  Arthur Jl Cooper; John T Pinto; Patrick S Callery
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-05-11       Impact factor: 4.481

6.  The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.

Authors:  Anna E Maciag; Harinath Chakrapani; Joseph E Saavedra; Nicole L Morris; Ryan J Holland; Ken M Kosak; Paul J Shami; Lucy M Anderson; Larry K Keefer
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

7.  Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines.

Authors:  Mohd A Yusuf; Trinette Chuang; G Jayarama Bhat; Kalkunte S Srivenugopal
Journal:  Free Radic Biol Med       Date:  2010-06-25       Impact factor: 7.376

8.  Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index.

Authors:  C Bossard; A Jarry; C Colombeix; K Bach-Ngohou; A Moreau; D Loussouarn; J-F Mosnier; C L Laboisse
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

9.  pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks.

Authors:  Ege Ulgen; Ozan Ozisik; Osman Ugur Sezerman
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

10.  Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study.

Authors:  Frédérique Souazé; Chantal Bou-Hanna; Christine Kandel; François Leclair; Julie Devallière; Béatrice Charreau; Stéphane Bézieau; Jean-François Mosnier; Christian L Laboisse
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.